Fibrosis research: Advances and challengesÂ
Drug Discovery World
JANUARY 24, 2024
Wigerinck has taken four drugs (Prezista, Olysio, Jyseleca and Rekambys) to market. PW: Through our exclusive access to one of the world’s largest fibrosis tissue biobanks, we have correlated disease progression to gene expression data, enabling us to discover novel targets on the pathway that drives the advanced stages of fibrotic disease.
59 
Let's personalize your content